E
Medicine Man Technologies, Inc.
SHWZ
$0.02
$0.01100.00%
E
Sell
3/11/2025Downgrade
Medicine Man Technologies, Inc. (SHWZ) was downgraded to E+ from D- on 3/11/2025 due to a decline in the volatility index.
Medicine Man Technologies, Inc. (SHWZ) was downgraded to E+ from D- on 3/11/2025 due to a decline in the volatility index.
D
Sell
2/7/2025Upgraded
Medicine Man Technologies, Inc. (SHWZ) was upgraded to D- from E+ on 2/7/2025 due to an increase in the volatility index and valuation index.
Medicine Man Technologies, Inc. (SHWZ) was upgraded to D- from E+ on 2/7/2025 due to an increase in the volatility index and valuation index.
E
Sell
6/20/2024Downgrade
Medicine Man Technologies, Inc. (SHWZ) was downgraded to E+ from D- on 6/20/2024 due to a decline in the total return index and volatility index.
Medicine Man Technologies, Inc. (SHWZ) was downgraded to E+ from D- on 6/20/2024 due to a decline in the total return index and volatility index.
D
Sell
3/28/2024Downgrade
Medicine Man Technologies, Inc. (SHWZ) was downgraded to D- from D on 3/28/2024 due to a substantial decline in the efficiency index, solvency index and valuation index. Net income declined 9,005.33% from -$322.5 to -$29.36M, debt to equity increased from 1.1 to 1.36, and total capital declined 5.47% from $329.17M to $311.16M.
Medicine Man Technologies, Inc. (SHWZ) was downgraded to D- from D on 3/28/2024 due to a substantial decline in the efficiency index, solvency index and valuation index. Net income declined 9,005.33% from -$322.5 to -$29.36M, debt to equity increased from 1.1 to 1.36, and total capital declined 5.47% from $329.17M to $311.16M.
D
Sell
8/14/2023Downgrade
Medicine Man Technologies, Inc. (SHWZ) was downgraded to D from D+ on 8/14/2023 due to a significant decline in the growth index, efficiency index and volatility index. Net income declined 478.57% from $1.75M to -$6.61M, earnings per share declined from -$0.0626 to -$0.15, and EBIT declined 12.26% from $5.65M to $4.96M.
Medicine Man Technologies, Inc. (SHWZ) was downgraded to D from D+ on 8/14/2023 due to a significant decline in the growth index, efficiency index and volatility index. Net income declined 478.57% from $1.75M to -$6.61M, earnings per share declined from -$0.0626 to -$0.15, and EBIT declined 12.26% from $5.65M to $4.96M.
D
Sell
5/22/2023Upgraded
Medicine Man Technologies, Inc. (SHWZ) was upgraded to D+ from D on 5/22/2023 due to a significant increase in the efficiency index, growth index and valuation index. Net income increased 106.38% from -$27.34M to $1.75M, earnings per share increased from -$0.5393 to -$0.0051, and total capital increased 2.74% from $280.39M to $288.06M.
Medicine Man Technologies, Inc. (SHWZ) was upgraded to D+ from D on 5/22/2023 due to a significant increase in the efficiency index, growth index and valuation index. Net income increased 106.38% from -$27.34M to $1.75M, earnings per share increased from -$0.5393 to -$0.0051, and total capital increased 2.74% from $280.39M to $288.06M.
D
Sell
2/28/2022Downgrade
Medicine Man Technologies, Inc. (SHWZ) was downgraded to D from D+ on 2/28/2022 due to a noticeable decline in the total return index, volatility index and valuation index.
Medicine Man Technologies, Inc. (SHWZ) was downgraded to D from D+ on 2/28/2022 due to a noticeable decline in the total return index, volatility index and valuation index.
D
Sell
2/7/2022Upgraded
Medicine Man Technologies, Inc. (SHWZ) was upgraded to D+ from D on 2/7/2022 due to an increase in the volatility index and valuation index.
Medicine Man Technologies, Inc. (SHWZ) was upgraded to D+ from D on 2/7/2022 due to an increase in the volatility index and valuation index.
D
Sell
11/16/2021Upgraded
Medicine Man Technologies, Inc. (SHWZ) was upgraded to D from D- on 11/16/2021 due to an increase in the solvency index.
Medicine Man Technologies, Inc. (SHWZ) was upgraded to D from D- on 11/16/2021 due to an increase in the solvency index.
D
Sell
11/8/2021Downgrade
Medicine Man Technologies, Inc. (SHWZ) was downgraded to D- from D on 11/08/2021.
Medicine Man Technologies, Inc. (SHWZ) was downgraded to D- from D on 11/08/2021.
D
Sell
11/3/2021Downgrade
Medicine Man Technologies, Inc. (SHWZ) was downgraded to D from D+ on 11/3/2021 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 1.93 to 1.86.
Medicine Man Technologies, Inc. (SHWZ) was downgraded to D from D+ on 11/3/2021 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 1.93 to 1.86.
D
Sell
4/6/2021Upgraded
Medicine Man Technologies, Inc. (SHWZ) was upgraded to D+ from D on 4/6/2021 due to a large increase in the total return index and volatility index.
Medicine Man Technologies, Inc. (SHWZ) was upgraded to D+ from D on 4/6/2021 due to a large increase in the total return index and volatility index.
D
Sell
4/8/2020Upgraded
Medicine Man Technologies, Inc. (MDCL) was upgraded to D from D- on 4/8/2020 due to an increase in the solvency index, volatility index and valuation index.
Medicine Man Technologies, Inc. (MDCL) was upgraded to D from D- on 4/8/2020 due to an increase in the solvency index, volatility index and valuation index.
D
Sell
3/19/2020Downgrade
Medicine Man Technologies, Inc. (MDCL) was downgraded to D- from D on 3/19/2020 due to a decline in the total return index and volatility index.
Medicine Man Technologies, Inc. (MDCL) was downgraded to D- from D on 3/19/2020 due to a decline in the total return index and volatility index.
D
Sell
11/13/2019Upgraded
Medicine Man Technologies, Inc. (MDCL) was upgraded to D from D- on 11/13/2019 due to a noticeable increase in the growth index, valuation index and efficiency index. Total capital increased 103.25% from $13.81M to $28.06M, total revenue increased 102.32% from $1.76M to $3.56M, and earnings per share increased from -$0.2955 to -$0.0521.
Medicine Man Technologies, Inc. (MDCL) was upgraded to D from D- on 11/13/2019 due to a noticeable increase in the growth index, valuation index and efficiency index. Total capital increased 103.25% from $13.81M to $28.06M, total revenue increased 102.32% from $1.76M to $3.56M, and earnings per share increased from -$0.2955 to -$0.0521.
D
Sell
8/19/2019Downgrade
Medicine Man Technologies, Inc. (MDCL) was downgraded to D- from D on 8/19/2019 due to a significant decline in the growth index, solvency index and efficiency index. Operating cash flow declined 396.28% from $373.6 to -$1.11M, net income declined 203% from -$2.91M to -$8.82M, and earnings per share declined from -$0.1044 to -$0.2955.
Medicine Man Technologies, Inc. (MDCL) was downgraded to D- from D on 8/19/2019 due to a significant decline in the growth index, solvency index and efficiency index. Operating cash flow declined 396.28% from $373.6 to -$1.11M, net income declined 203% from -$2.91M to -$8.82M, and earnings per share declined from -$0.1044 to -$0.2955.
D
Sell
5/21/2019Downgrade
Medicine Man Technologies, Inc. (MDCL) was downgraded to D from D+ on 5/21/2019 due to a noticeable decline in the efficiency index and solvency index. The quick ratio declined from 1.42 to 0.5, and total capital declined 8.72% from $17.07M to $15.59M.
Medicine Man Technologies, Inc. (MDCL) was downgraded to D from D+ on 5/21/2019 due to a noticeable decline in the efficiency index and solvency index. The quick ratio declined from 1.42 to 0.5, and total capital declined 8.72% from $17.07M to $15.59M.
D
Sell
5/2/2019Upgraded
Medicine Man Technologies, Inc. (MDCL) was upgraded to D+ from D on 5/2/2019 due to a major increase in the total return index, growth index and volatility index.
Medicine Man Technologies, Inc. (MDCL) was upgraded to D+ from D on 5/2/2019 due to a major increase in the total return index, growth index and volatility index.
D
Sell
4/17/2019Downgrade
Medicine Man Technologies, Inc. (MDCL) was downgraded to D from C- on 4/17/2019 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.1795 to -$0.2371, net income declined 185.01% from $4.95M to -$4.21M, and operating cash flow declined 156.59% from $4.94M to -$2.8M.
Medicine Man Technologies, Inc. (MDCL) was downgraded to D from C- on 4/17/2019 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.1795 to -$0.2371, net income declined 185.01% from $4.95M to -$4.21M, and operating cash flow declined 156.59% from $4.94M to -$2.8M.
C
Hold
12/28/2018Upgraded
Medicine Man Technologies, Inc. (MDCL) was upgraded to C- from D+ on 12/28/2018 due to an increase in the valuation index and volatility index.
Medicine Man Technologies, Inc. (MDCL) was upgraded to C- from D+ on 12/28/2018 due to an increase in the valuation index and volatility index.
D
Sell
12/10/2018Downgrade
Medicine Man Technologies, Inc. (MDCL) was downgraded to D+ from C- on 12/10/2018 due to a decline in the total return index and volatility index.
Medicine Man Technologies, Inc. (MDCL) was downgraded to D+ from C- on 12/10/2018 due to a decline in the total return index and volatility index.
C
Hold
11/14/2018Upgraded
Medicine Man Technologies, Inc. (MDCL) was upgraded to C- from D on 11/14/2018 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 2,624.66% from $181.7 to $4.95M, earnings per share increased from $0.0073 to $0.1795, and EBIT increased 1,313.19% from $153.2 to $2.17M.
Medicine Man Technologies, Inc. (MDCL) was upgraded to C- from D on 11/14/2018 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 2,624.66% from $181.7 to $4.95M, earnings per share increased from $0.0073 to $0.1795, and EBIT increased 1,313.19% from $153.2 to $2.17M.
D
Sell
8/14/2018Upgraded
Medicine Man Technologies, Inc. (MDCL) was upgraded to D from D- on 8/14/2018 due to a substantial increase in the growth index, efficiency index and solvency index. EBIT increased 751.11% from $18 to $153.2, net income increased 615.35% from $25.4 to $181.7, and earnings per share increased from $0.0011 to $0.0073.
Medicine Man Technologies, Inc. (MDCL) was upgraded to D from D- on 8/14/2018 due to a substantial increase in the growth index, efficiency index and solvency index. EBIT increased 751.11% from $18 to $153.2, net income increased 615.35% from $25.4 to $181.7, and earnings per share increased from $0.0011 to $0.0073.
D
Sell
3/28/2018Downgrade
Medicine Man Technologies, Inc. (MDCL) was downgraded to D- from D on 3/28/2018 due to a decline in the growth index and efficiency index. EBIT declined 77.52% from -$277.1 to -$491.9, net income declined 5.5% from -$485.6 to -$512.3, and total capital declined 2.98% from $11.13M to $10.8M.
Medicine Man Technologies, Inc. (MDCL) was downgraded to D- from D on 3/28/2018 due to a decline in the growth index and efficiency index. EBIT declined 77.52% from -$277.1 to -$491.9, net income declined 5.5% from -$485.6 to -$512.3, and total capital declined 2.98% from $11.13M to $10.8M.
D
Sell
3/21/2018Upgraded
Medicine Man Technologies, Inc. (MDCL) was upgraded to D from D- on 3/21/2018 due to a noticeable increase in the total return index, volatility index and valuation index.
Medicine Man Technologies, Inc. (MDCL) was upgraded to D from D- on 3/21/2018 due to a noticeable increase in the total return index, volatility index and valuation index.
D
Sell
10/3/2016Upgraded
Medicine Man Technologies, Inc. (MDCL) was upgraded to D- from E on 10/3/2016 due to an increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0115 to -$0.0099, and EBIT increased 10.89% from -$113.9 to -$101.5.
Medicine Man Technologies, Inc. (MDCL) was upgraded to D- from E on 10/3/2016 due to an increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0115 to -$0.0099, and EBIT increased 10.89% from -$113.9 to -$101.5.
E
Sell
7/1/2016Upgraded
Medicine Man Technologies, Inc. (SHWZ) was upgraded to E from E- on 07/01/2016.
Medicine Man Technologies, Inc. (SHWZ) was upgraded to E from E- on 07/01/2016.
E
Sell
4/19/2016None
Medicine Man Technologies, Inc. (SHWZ) was downgraded to E- from U on 04/19/2016.
Medicine Man Technologies, Inc. (SHWZ) was downgraded to E- from U on 04/19/2016.
OTC PK
03/14/2025 1:58PM Eastern
Quotes delayed
